CONGIU, CENZO
 Distribuzione geografica
Continente #
EU - Europa 142.344
NA - Nord America 9.062
AS - Asia 3.742
SA - Sud America 547
AF - Africa 126
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 6
Totale 155.835
Nazione #
IT - Italia 133.114
US - Stati Uniti d'America 8.947
NL - Olanda 6.666
CN - Cina 1.428
SG - Singapore 1.399
UA - Ucraina 909
BR - Brasile 445
FI - Finlandia 402
SE - Svezia 353
DE - Germania 331
VN - Vietnam 287
GB - Regno Unito 217
FR - Francia 208
HK - Hong Kong 125
IN - India 110
KR - Corea 101
CA - Canada 69
BD - Bangladesh 54
MA - Marocco 45
RU - Federazione Russa 40
AR - Argentina 38
JP - Giappone 28
MX - Messico 28
EG - Egitto 26
IQ - Iraq 25
PK - Pakistan 24
ES - Italia 21
TR - Turchia 20
EC - Ecuador 19
ID - Indonesia 18
ZA - Sudafrica 18
BE - Belgio 17
VE - Venezuela 16
AT - Austria 13
CO - Colombia 12
IR - Iran 12
SA - Arabia Saudita 12
JO - Giordania 11
TN - Tunisia 11
UZ - Uzbekistan 10
MY - Malesia 9
TW - Taiwan 9
AZ - Azerbaigian 8
PH - Filippine 8
PT - Portogallo 8
TH - Thailandia 8
IE - Irlanda 7
IL - Israele 7
OM - Oman 7
PL - Polonia 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
CL - Cile 6
CZ - Repubblica Ceca 6
EU - Europa 6
HU - Ungheria 6
JM - Giamaica 6
KE - Kenya 6
PE - Perù 6
CR - Costa Rica 5
NP - Nepal 5
DZ - Algeria 4
LT - Lituania 4
NG - Nigeria 4
RS - Serbia 4
KZ - Kazakistan 3
RO - Romania 3
UY - Uruguay 3
CI - Costa d'Avorio 2
DK - Danimarca 2
GA - Gabon 2
LB - Libano 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SN - Senegal 2
TT - Trinidad e Tobago 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MN - Mongolia 1
MU - Mauritius 1
PA - Panama 1
PY - Paraguay 1
RE - Reunion 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
ZW - Zimbabwe 1
Totale 155.835
Città #
Cagliari 130.167
Amsterdam 6.650
Uta 2.489
Woodbridge 893
Fairfield 742
Ashburn 640
Singapore 605
Chandler 539
Houston 536
Jacksonville 520
San Jose 438
Wilmington 432
Ann Arbor 416
Dallas 405
Boardman 393
Seattle 302
Cambridge 282
Helsinki 252
Nyköping 247
Beijing 215
Dearborn 154
Nanjing 148
Boston 125
Los Angeles 123
Hefei 120
Lauterbourg 115
Santa Clara 106
Hong Kong 98
Ho Chi Minh City 94
Munich 90
The Dalles 89
Council Bluffs 86
Seoul 84
Shanghai 74
New York 73
Buffalo 69
Nanchang 61
Hanoi 55
Shenyang 53
Milan 50
Hebei 46
San Diego 44
Guangzhou 40
Verona 40
Jiaxing 39
Tianjin 37
Toronto 37
São Paulo 36
Changsha 34
Redwood City 34
Dong Ket 32
Casablanca 31
Mountain View 29
Redondo Beach 29
Atlanta 25
Auburn Hills 23
Norwalk 23
Olbia 23
Washington 22
Orange 21
Chicago 20
Frankfurt am Main 19
Tokyo 19
Zhengzhou 19
Brooklyn 18
Phoenix 18
Jinan 17
London 17
Turku 16
Selargius 15
Belo Horizonte 14
Chennai 14
Columbus 14
Ferrara 14
Hangzhou 14
Sassari 14
Falls Church 13
Rome 13
Brussels 12
Cairo 12
Da Nang 12
San Francisco 12
Dhaka 11
Ningbo 11
Nuremberg 11
Orem 11
Wuhan 11
Amman 10
Haiphong 10
Manchester 10
Perugia 10
Quito 10
Rio de Janeiro 10
Kunming 9
Naples 9
Baghdad 8
Brasília 8
Chapel Hill 8
Denver 8
Indiana 8
Totale 150.184
Nome #
Synthesis and antiproliferative activity of 2,6-Dibenzylamino-3,5-dicyanopyridines on human cancer cell lines 12.498
Synthesis and biological evaluation of novel acylhydrazone derivatives as potential antitumor agents 6.606
Inhibition of fatty acid amide hydrolase and cyclooxygenase by the N-(3-methylpyridin-2-yl)amide derivatives of flurbiprofen and naproxen 4.904
Attività antimicobatterica di nuovi S-alchilisotiosemicarbazoni e potenziamento dell'attività di rifabutina, rifampicina e amikacina nei confronti di Mycobacterium avium 4.608
Inhibitory effect of positively charged triazine antagonists of prokinecitin receptors on the transient receptor vanilloid type-1 (TRPV1) channel 2.863
Dihydroquinazoline and Triazinedione Derivatives as Prok1 and Prok2 receptor antagonists in HEK-293 transfected cells 2.734
Synthesis and carbonic anhydrase I, II, IX and XII inhibitory activity of sulfamates incorporating piperazinyl-ureido moieties 2.714
TRPV1 modulators: synthesis and in vitro evaluation of 1-heteroarylpiperidinecarboxamide and piperazinylurea derivatives 2.665
A new convenient synthetic method and preliminary pharmacological characterization of triazinediones as prokineticin receptor antagonists 2.601
Interaction of the N-(3-Methylpyridin-2-yl)amide derivatives of flurbiprofen and ibuprofen with FAAH: Enantiomeric selectivity and binding mode 2.544
Design, synthesis, and anti-HIV-1 activity of 1-substituted 3-(3,5-dimethylbenzyl)triazine derivatives 2.531
Critical role for prokineticin 2 in CNS autoimmunity 2.463
Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity 2.368
Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide 2.356
Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor 2.354
Halogenated triazinediones behave as antagonists of PKR1: in vitro and in vivo pharmacological characterization 2.251
Synthesis and evaluation of new pyrazole-based carboxamides as modulators of the TrPv1 channel 2.207
New bis(pyridyl)methane derivatives from 4-hydroxy-2-pyridones: synthesis and antitumoral activity 2.205
Antagonism of the prokineticin system prevents and reverses allodynia and inflammation in a mouse model of diabetes 2.127
Investigation of the mechanism of FAAH inhibition of profen amide derivatives 2.124
Simple synthesis of polyfunctional nitropyridines 2.088
A new and efficient synthesis of phthalazin-1(2H)-ones 2.066
Synthesis of triflouromethylated pyridinecarbonitriles 2.055
Synthesis and SIRT1 modulation studies of amides and hydrazides of benzoic acid incorporating a (2-trifluoromethylpyridin-4-yl)amino moiety 2.051
2-Acylhydrazino-5-arylpyrrole derivatives: Synthesis and antifungal activity evaluation 2.008
A novel inhibitor of fatty acid amide hydrolase, the enzyme responsible for the hydrolysis of the endocannabinoid anandamide 1.974
Interaction and reactivity of synthetic aminoisoflavones with metal-free and metalassociated amyloid-beta 1.906
A novel inhibitor of fatty acid amide hydrolase, the enzyme responsible for the hydrolysis of the endocannabinoid anandamide 1.846
An important role for prokineticin 2 in autoimmune CNS demyelination 1.814
PPAR controls pregnancy outcome through activation of EG-VEGF: new insights into the mechanism of placental development 1.810
Synthesis and antitumor evaluation of 6-thioxo-, 6-oxo- and 2,4-dioxopyrimidine derivatives 1.807
Synthesis and carbonic anhydrase I, II, IX and XII inhibition studies of 4-N,N-disubstituted sulfanilamides incorporating 4,4,4-trifluoro-3-oxo-but-1-enyl, phenacylthiourea and imidazol-2(3H)-one/thione moieties 1.793
null 1.768
Reaction of enaminonitriles with isocyanates. Synthesis of new 2-oxo- and 6-oxopyrimidines 1.758
null 1.650
Synergistic interaction in vitro between rifabutin and newly synthesized S-alkylisothiosemicarbazones derivatives against mycobacterium avium 1.466
DESIGN, SYNTHESIS, AND EVALUATION OF (ISO)NIPECOTAMIDE AND PIPERAZINYLUREA DERIVATIVES AS TRPV1 MODULATORS 1.380
Flavones and structurally related 4-chromenones inhibit carbonic anhydrases by a different mechanism of action compared to coumarins 1.351
Synergistic interactions in vitro between Rifabutin and newly synthesized s-alkylthiosemicarbazone derivatives against M. avium 1.279
New trifluoromethylated pyridines from functionalized N-1-acylacetamidrazones 1.252
null 1.242
Novel 2-amino-isoflavones exhibit aryl hydrocarbon receptor agonist or antagonist activity in a species/cell-specific context 1.239
Prokineticin receptor 1 antagonist PC-10 as a biomarker for imaging inflammatory pain 1.167
Synthesis of ibuprofen heterocyclic amides and investigation of their analgesic and toxicological properties 1.096
Synthesis and Carbonic Anhydrase Inhibitory Activity of New 2-Aminochromenone Derivatives 912
Further studies on the effect of lysine at the C-terminus of the Dmt-Tic opioid pharmacophore 843
Synthesis and biological activity of prokineticin receptors antagonists and their development as a biomarker for imaging inflammatory pain 832
null 825
Reactivity of N1-Acylacetamidrazones towards Diethyl Acetylenedicarboxylate: Cyclization to Ethyl Pyrroleacetates and 1-Acylaminopyridones 822
Design, Synthesis and Evaluation of new 2-(Arylidenehydrazino)pyrrole Derivatives as Potential Antitumor Agents 808
Synthesis and in vitro antitumoral activity of new hydrazinopyrimidine-5-carbonitrile derivatives 749
null 731
Synthesis and in vitro antitumor activity of new 4,5-dihydropyrazole derivatives 729
Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors 724
In vitro antimycobacterial activity of newly synthesised S-alkylisothiosemicarbazone derivatives and synergistic interactions in combination with rifamycins against Mycobacterium avium 711
Synthesis and evaluation of anticancer activity of 2-arylamino-6-trifluoromethyl-3-(hydrazonocarbonyl)pyridines 707
null 670
Synthesis of new N-(2-(trifluoromethyl)pyridin-4-yl)anthranilic acid derivatives and their evaluation as anticancer agents 661
DESIGN, SYNTHESIS, BIOLOGICAL ACTIVITY AND SAR OF DUAL FAAH – COX INHIBITORS 628
Design, synthesis, and in vitro antitumor activity of new 1,4-diarylimidazole-2-ones and their 2-thione analogues 616
null 613
Synthesis and evaluation of antitumoral activity of ester and amide derivatives of 2-arylamino-6- trifluoromethyl-3-pyridinecarboxylic acids 612
Synthesis and structural studies of 3-acylamino-4-amino-2,3-dihydro-2-iminothiazole-5-carboxylates and 4-acylhydrazino-2-aminothiazole-5-carboxylates 567
Effect of lysine at C-terminus of the Dmt-Tic opioid pharmacophore 562
Synthesis and antimicrobial activity of some pyrrole derivatives 515
Synthesis and antimicrobial activity of some 1-arylideneamino-2-mercaptoimidazole derivatives 496
null 466
null 457
Synthesis and antimicrobial activity of some pyrrole derivatives. III. 2-(4-arylpiperazino)-3-ethoxycarbonyl-5-aryl-pyrrole derivatives. 448
Synthesis and antimicrobial activity of some pyrrole derivatives. IV. 2-arylidenhydrazino-3-ethoxycarbonyl (or cyano) pyrrole derivatives. 441
Synthesis and in vitro antitumoral activity of new N-phenyl-3-pyrrolecarbothioamides 436
Design, synthesis and pharmacological investigation on new FAAH inhibitors 426
null 424
Attività antimicrobica di derivati pirrolici 419
DESIGN, SYNTHESIS, BIOLOGICAL ACTIVITY AND SAR OF NEW FAAH INHIBITORS 418
null 416
null 414
PROGETTAZIONE, SINTESI, STUDI SAR E VALUTAZIONE BIOLOGICA DI NUOVIINIBITORI DELL’ENZIMA FAAH 406
Synthesis and structure of heterocyclic compounds, 1-amino-2,4-disubstituted imidazoles. 392
Synthesis of 1-acyl-5-pyrazolones and pyrrolidino [2,3-c]pyrazol-3-ones 387
Synergistic activity between rifamycins and a new class of isothiosemicarbazones against Mycobacterium avium 383
Design, Synthesis, Biological Activity and SAR of New FAAH Inhibitors 382
Synthesis of 6-amino and 6-ethoxy-2(1H)-pyridone derivatives. 380
Attività antimicobatterica di nuovi S-alchilisotiosemicarbazoni e potenziamento dell'attività di rifampicina e rifabutina nei confronti di Mycobacterium avium 379
Synthesis and antifungal activities of N-arylideneaminoimidazole derivatives. 378
null 378
DERIVATI DIARILETEROCICLICI COME POTENZIALI AGENTI ANTITUMORALI 370
Synthesis and in vitro antitumoral activity of new 3,5-dicyanopyridine derivatives 369
null 361
Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis 354
Synthesis and antimycobacterial activity of new S-alkylisotiosemicarbazone derivatives 352
Attività Antimicobatterica di Nuovi S-alchilisotiosemicarbazoni e Potenziamento dell’Attività di Rifampicina e Rifabutina nei Confronti di M. Avium 351
null 350
null 341
null 341
Synthesis and Antitubercular activity of N1-Isonicotinoylamidrazones Derivatives 341
Synergistic Activity between Rifamycins and a New Class of Isothiosemicarbazones against Mycobacterium avium 338
Concentrazioni sub-inibenti di isonicotinoilidrazoni potenziano l'attività di rifampicina e etambutolo nei confronti di Mycobacterium tuberculosis 335
null 332
Synthesis of pyridines by heterocyclization of new dienamino esters. 331
Totale 136.018
Categoria #
all - tutte 202.646
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 202.646


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.102 0 0 0 0 0 0 0 0 0 0 0 1.102
2021/20224.171 381 345 336 236 225 315 313 293 281 470 353 623
2022/20237.334 730 726 657 519 535 908 490 1.070 467 345 575 312
2023/20249.379 422 365 449 713 975 1.628 1.563 546 446 645 743 884
2024/202555.285 20.762 13.225 13.053 2.052 1.635 1.129 1.205 155 327 1.260 194 288
2025/202611.709 299 410 844 747 289 352 950 577 5.939 820 393 89
Totale 156.159